AI assistant
Sending…
RESMED INC — Director's Dealing 2013
Mar 5, 2013
30071_dirs_2013-03-05_1d4d917f-c045-414d-ba4d-5a4f7b106487.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-03-01
Reporting Person: Hollingshead James (President, Americas)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 1161.7927 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| ResMed Restricted Stock Units | $0 | ResMed Common Stock (28572) | Direct | ||
| ResMed Restricted Stock Units | $0 | ResMed Common Stock (28571) | Direct | ||
| ResMed Restricted Stock Units | $0 | ResMed Common Stock (40000) | Direct |
Footnotes
F1: Represents date RSUs first became exercisable. RSUs vest 1/4 per year on the anniversary of the grant.
F2: RSUs do not have an expiration date.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29